The MMS Cost Benefit Tool

Test scenarios or run a custom analysis to find the benefit of switching to MMS.

Recent evidence has encouraged low- and middle-income countries to consider transitioning from long-standing iron and folic acid supplementation (IFAS) to multiple micronutrient supplementation (MMS) for antenatal care programs. However, global guidance to facilitate this transition is limited.

This tool was developed to aid countries’ decision-making. It uses a rigorous methodology to calculate the incremental benefits and costs of transitioning from IFAS to MMS in various countries (Kashi et al., 2018).

Users can construct and test different scenarios by updating the assumptions within the tool or running a Custom Analysis. Up to eight health outcomes are included in the analysis, and aggregated using disability-adjusted life years (DALYs).

Policy Briefs

Customized policy briefs that reflect individual countries' reality.

Policy Briefs are available for the countries listed on the map. These documents summarize the results of the analysis and are designed for policymakers to answer the question “is antenatal MMS better value for money than IFAS?”